Yi Chen
Eli Lilly and Company
8 Papers
65 Citations
Yi Chen is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Fibromyalgia & Observational study. The author has an hindex of 7, co-authored 8 publications.
Chat about Author
Papers
Long-term evaluation of opioid treatment in fibromyalgia.
Xiaomei Peng,Rebecca L. Robinson,Philip J. Mease,Kurt Kroenke,Kurt Kroenke,David A. Williams,Yi Chen,Douglas E. Faries,Madelaine M. Wohlreich,Bill McCarberg,Danette Hann +10 more
TL;DR: Overall, the findings show little support for the long-term use of opioid medications in patients with fibromyalgia given the poorer outcomes across multiple assessment domains associated with this cohort.
77
MUSCULOSKELETAL PAIN SECTION Original Research Article Burden of Illness and Treatment Patterns for Patients with Fibromyalgia
Rebecca L. Robinson,Kurt Kroenke,Philip J. Mease,David R. Williams,Yi Chen,Madelaine M. Wohlreich,Bill H. McCarberg,Swedish Medical +7 more
- 01 Jan 2012
TL;DR: Burden of illness was high for patients with FM, and treatment patterns were highly variable, Importantly, the treatments with the most evidence to support their use were not always the most frequently chosen.
46
Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder
X Liu,Yi Chen,Douglas E. Faries +2 more
TL;DR: Among SNRIs, duloxetine had statistically significantly better adherence and persistence than venlafaxine XR, though differences were relatively small and further research is needed to assess whether these translate into clinically and economically meaningful outcomes.
Local control for identifying subgroups of interest in observational research: persistence of treatment for major depressive disorder.
TL;DR: The use of this two‐step strategy using local control plus CART to identify depression patients most (least) likely to benefit from treatment with duloxetine relative to extended‐release venlafaxine is demonstrated.
Variations in the management of fibromyalgia by physician specialty: rheumatology versus primary care.
Stephen L. Able,Rebecca L. Robinson,Kurt Kroenke,Philip J. Mease,David R. Williams,Yi Chen,Madelaine M. Wohlreich,Bill H. McCarberg +7 more
- 20 May 2016
TL;DR: The small but significant differences reported by physicians and patients across physician cohorts suggest that despite published guidelines, treatment of FM still contains important variance across specialties.